Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Seattle Genetics molecule inhibits fucosylation in vitro and in vivo

May 10, 2012

New Kyowa Hakko Kirin product demonstrates anticancer activity

May 10, 2012

Novel anticancer compounds synthesized at Nerviano Medical Sciences

May 10, 2012

Rexahn Pharmaceuticals submits ovarian cancer study protocol to FDA

May 9, 2012

GTx gives update on Capesaris IND

May 9, 2012

FDA provides update on Revlimid

May 9, 2012

Roche submits application for anticancer drug in Australia

May 9, 2012

Genta begins phase II trial of tesetaxel in gastric cancer

May 9, 2012

Generon begins phase II trial of F-627

May 9, 2012

Exonhit describes novel tubulin polymerization inhibitor

May 9, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...